Overview (18 Sep 2026)
Valiant Laboratories Ltd
VALIANTLAB
INE0JWS01017

Pharmaceuticals
Result was last declared on 20 May 2025
0.51

Prev. Close
Previous Close
122.75
Current Close
123.26
Current High
128.88
Current Low
121
52 Week High
129.9
52 Week Low
50
Resistance 1
127.76
Resistance 2
132.26
Support 1
119.88
Support 2
112.00
Std Deviation
18.65%
DMA 200
70.82
DMA 50
84.68
DMA 20
109.32
Fundamentals and Ratios
Standalone
Trailing EPS
1.02
Forwad EPS
3.21
Trailing P/E
120.84
Forward P/E
38.36
PEG Ratio
0.42
Mkt. Cap (Cr)
Market Cap (Cr)
669.46
Total Debt(Cr)
Tot. Debt(Cr)
44.95
Reserve (Cr)
256.57
Book Value
57.36
P/BV Ratio
2.15
ROCE(%)
5.00
ROE
6.00
Consolidated
Trailing EPS
0
Forwad EPS
3.88
Trailing P/E
88.85
Forward P/E
31.77
PEG Ratio
-0.06
Mkt. Cap (Cr)
Market Cap (Cr)
669.46
Total Debt(Cr)
Tot. Debt(Cr)
45.42
Reserve (Cr)
256.57
Book Value
57.25
P/BV Ratio
2.15
ROCE(%)
8.35
ROE
5.1500

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue73.4265.354.7445.9951.01217.04
Other Income0.850.770.610.850.672.89
Total Income74.2766.0855.3546.8351.68219.94
Interest0.080.020.040.140.070.26
Expenditure-61.55-61.34-55.24-46.58-49.23-212.39
PBDT0.000.000.000.000.000.00
Depreciation-0.55-0.52-0.72-0.51-0.51-2.26
PBT12.734.730.110.262.457.55
Tax-3.25-1.20-0.08-0.09-0.63-2.00
Equity54.3154.310.000.0043.4543.45
OPM17.147.160.200.564.743.43
Net Profit9.483.530.030.171.825.55
NPM12.765.340.060.363.522.52
EPS1.750.650.010.030.421.02
Consolidated
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue115.2991.9852.4646.246.82237.468
Other Income0.860.170.630.870.662.32
Total Income116.1592.1553.0947.0747.48239.79
Interest1.071.010.000.140.071.90
Expenditure-89.95-91.11-56.08-46.79-45.03-239.02
PBDT0.000.000.000.000.000.00
Depreciation-2.86-2.930.00-0.53-0.53-6.04
PBT26.191.050.000.282.450.77
Tax-5.090.71-4.07-0.08-0.63-4.04
Equity54.3154.310.000.0043.4554.31
OPM22.551.140.000.595.160.32
Net Profit21.11.76-7.060.21.82-3.27
NPM18.171.91-13.290.423.83-1.36
EPS3.890.3200.040.420
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings